Genscript Sales General And Administrative To Revenue from 2010 to 2024

Pink Sheets . USA . 
Stock . Genscript Biotech
GNNSF Stock  USD 1.37  0.01  0.72%   
Check Genscript Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genscript Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genscript financial statements analysis is a perfect complement when working with Genscript Biotech Valuation or Volatility modules.
  
This module can also supplement various Genscript Biotech Technical models . Check out the analysis of Genscript Biotech Correlation against competitors.

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Genscript Pink Sheet

Genscript Biotech financial ratios help investors to determine whether Genscript Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genscript with respect to the benefits of owning Genscript Biotech security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY